Aethlon Financial Statements From 2010 to 2026

AEMD Stock  USD 2.92  0.21  7.75%   
Aethlon Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Aethlon Medical's valuation are provided below:
Gross Profit
574.2 K
Market Capitalization
2.8 M
Enterprise Value Revenue
1.0661
Revenue
574.2 K
Earnings Share
209.2
There are over one hundred nineteen available fundamental signals for Aethlon Medical, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Aethlon Medical's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of January 19, 2026, Market Cap is expected to decline to about 4.9 M. The current year's Enterprise Value is expected to grow to about (423.4 K)

Aethlon Medical Total Revenue

0.0

Check Aethlon Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aethlon Medical's main balance sheet or income statement drivers, such as Interest Expense of 11 K, Other Operating Expenses of 10.2 M or Total Operating Expenses of 11.3 M, as well as many indicators such as Price To Sales Ratio of 119, Dividend Yield of 0.0 or PTB Ratio of 0.82. Aethlon financial statements analysis is a perfect complement when working with Aethlon Medical Valuation or Volatility modules.
  
Build AI portfolio with Aethlon Stock
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Aethlon Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.9 M8.5 M6.5 M
Slightly volatile
Other Current Liabilities1.8 M1.2 M1.6 M
Slightly volatile
Total Current Liabilities2.8 M1.7 M3.1 M
Slightly volatile
Cash6.6 M6.3 M5.4 M
Slightly volatile
Non Current Assets Total1.7 M1.6 M720.7 K
Slightly volatile
Non Currrent Assets Other53.2 K30 K34.5 K
Slightly volatile
Cash And Short Term Investments6.6 M6.3 M5.4 M
Slightly volatile
Common Stock Total Equity13.3 K14 K39.6 K
Slightly volatile
Common Stock Shares Outstanding188.5 K179.5 K90.1 K
Slightly volatile
Liabilities And Stockholders Equity8.9 M8.5 M6.5 M
Slightly volatile
Other Stockholder Equity209 M199.1 M113.9 M
Slightly volatile
Total LiabilitiesM2.6 M3.6 M
Slightly volatile
Total Current Assets7.2 M6.8 M5.8 M
Slightly volatile
Common Stock2.8 KK24.1 K
Slightly volatile
Accounts Payable553.7 K481.1 K443.2 K
Very volatile
Short Term Debt267.6 K281.7 K773.1 K
Slightly volatile
Property Plant And Equipment Net1.5 M1.5 M610.3 K
Slightly volatile
Property Plant And Equipment Gross2.7 M2.6 M861.9 K
Slightly volatile
Intangible Assets47049556.3 K
Slightly volatile
Short and Long Term Debt Total933.3 K584.8 K1.1 M
Slightly volatile
Current Deferred Revenue183.2 K192.8 K577.3 K
Slightly volatile
Other Assets0.860.956.8 K
Slightly volatile
Other Current Assets541.6 K515.8 K318.2 K
Slightly volatile
Property Plant Equipment2.8 M2.6 M827.2 K
Slightly volatile
Capital Surpluse97.7 M148.7 M99.9 M
Slightly volatile
Long Term Debt Total620.4 K967.3 K742.6 K
Slightly volatile
Short and Long Term Debt735 K866.1 K1.2 M
Slightly volatile
Net Invested Capital9.9 M5.9 M8.1 M
Pretty Stable
Net Working CapitalM4.7 M7.4 M
Pretty Stable
Capital Stock2.2 K2.3 K14.2 K
Slightly volatile
Capital Lease Obligations680.6 K747.2 K377 K
Slightly volatile
Non Current Liabilities Other34 K38.3 K41.8 K
Slightly volatile

Aethlon Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses10.2 M10.7 M7.2 M
Slightly volatile
Total Operating Expenses11.3 M10.7 M7.3 M
Slightly volatile
Depreciation And Amortization320.9 K305.6 K117.9 K
Slightly volatile
Cost Of Revenue371 K390.5 K1.5 B
Pretty Stable
Selling General Administrative11.3 M10.7 M5.6 M
Slightly volatile
Research Development2.7 M2.5 M1.6 M
Slightly volatile
Selling And Marketing Expenses3.6 M6.5 M3.5 M
Slightly volatile
Reconciled Depreciation410 K390.5 K132.1 K
Slightly volatile

Aethlon Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow6.7 M6.4 M5.1 M
Slightly volatile
End Period Cash Flow6.8 M6.4 M5.4 M
Slightly volatile
Total Cash From Financing Activities9.3 M8.9 M6.1 M
Slightly volatile
Depreciation173.8 K305.6 K109.2 K
Slightly volatile
Stock Based Compensation355 K373.7 K846 K
Pretty Stable
Change To Netincome1.6 M1.1 M1.9 M
Slightly volatile
Issuance Of Capital Stock5.9 M3.2 M4.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1191252.8 K
Slightly volatile
Days Sales Outstanding80.47143118
Slightly volatile
Average Payables227.8 K239.8 K349.4 K
Slightly volatile
Stock Based Compensation To Revenue1.941.652.1914
Pretty Stable
Capex To Depreciation0.860.631.9748
Very volatile
EV To Sales93.4598.362.8 K
Slightly volatile
Payables Turnover22.1 K21 K19.6 K
Slightly volatile
Sales General And Administrative To Revenue6.4211.778.4705
Slightly volatile
Research And Ddevelopement To Revenue4.524.33.009
Slightly volatile
Capex To Revenue1.551.480.5912
Slightly volatile
Cash Per Share30.1331.72198
Pretty Stable
Days Payables Outstanding0.01710.01824.0465
Slightly volatile
Income Quality0.450.510.6799
Very volatile
Intangibles To Total Assets1.0E-41.0E-40.0717
Slightly volatile
Current Ratio2.152.824.8399
Pretty Stable
Receivables Turnover2.512.643.9528
Slightly volatile
Capex Per Share1.091.158.4502
Slightly volatile
Average Receivables79.7 K57.6 K109.6 K
Slightly volatile
Revenue Per Share3.053.22120
Slightly volatile
Interest Debt Per Share4.624.86360
Slightly volatile
Debt To Assets0.09650.10.7736
Slightly volatile
Operating Cycle80.47143118
Slightly volatile
Days Of Payables Outstanding0.01710.01824.0465
Slightly volatile
Ebt Per Ebit1.721.651.5073
Slightly volatile
Effective Tax Rate0.00480.00460.004
Slightly volatile
Quick Ratio2.152.824.8399
Pretty Stable
Net Income Per E B T1.131.151.0118
Slightly volatile
Cash Ratio2.032.614.5682
Pretty Stable
Days Of Sales Outstanding80.47143118
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.921.0064
Slightly volatile
Fixed Asset Turnover0.270.29615
Slightly volatile
Debt Ratio0.09650.10.7736
Slightly volatile
Price Sales Ratio1191252.8 K
Slightly volatile
Asset Turnover0.03580.03771.9495
Slightly volatile

Aethlon Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.9 M5.1 M141.8 M
Slightly volatile

Aethlon Fundamental Market Drivers

Forward Price Earnings0.2102
Cash And Short Term Investments5.5 M

Aethlon Upcoming Events

12th of February 2024
Upcoming Quarterly Report
View
26th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of June 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

About Aethlon Medical Financial Statements

Aethlon Medical stakeholders use historical fundamental indicators, such as Aethlon Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aethlon Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aethlon Medical's assets and liabilities are reflected in the revenues and expenses on Aethlon Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aethlon Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue192.8 K183.2 K
Cost Of Revenue390.5 K371 K
Stock Based Compensation To Revenue 1.65  1.94 
Sales General And Administrative To Revenue 11.77  6.42 
Research And Ddevelopement To Revenue 4.30  4.52 
Capex To Revenue 1.48  1.55 
Revenue Per Share 3.22  3.05 
Ebit Per Revenue(23.83)(25.02)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
209.2
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.55)
Return On Equity
(1.91)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.